Trump’s 100% tariffs on branded drugs: Indian generics spared but poses risks for pharma sector – Explained
US President Trump announced a 100% tariff on imported branded and patented pharmaceuticals starting October 2025, aiming to boost domestic manufacturing. Indian generic drug makers ...
Top stocks to buy today: Stock market recommendations for August 26, 2025 – check list
Stock market recommendations: Mirae Asset Sharekhan’s Somil Mehta recommends buying Sun Pharma and Bharti Airtel. Sun Pharma, exhibiting a breakout from a triangle pattern, is ...
Compliance review: Sun Pharma’s Halol plant gets 8 USFDA observations; company vows remedial steps after inspection
Sun Pharmaceutical Industries faces scrutiny. The USFDA issued a Form 483. This follows an inspection of its Halol manufacturing plant in Gujarat. The inspection occurred ...
Sun Pharma elevates Kirti Ganorkar as MD; Dilip Shanghvi to stay on as exec chairman
Sun Pharma’s India business head, Kirti Ganorkar, will become the managing director on September 1, succeeding founder Dilip Shanghvi. Shanghvi will transition to executive chairman, ...
